Heparin Completed Phase 3 Trials for Persistent Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00171769Atrial Fibrillation Feasibility Certoparin Trial - AFFECT